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Diego Galagovskya, Maximiliano J. Katza,b,*, Julieta M. Acevedoa,b,*, Eleonora Sorianelloa,b, 
Alvaro Glavicc, and Pablo Wappnera,b,d
aInstituto Leloir, Buenos Aires C1405BWE, Argentina; bNational Scientific and Technical Research Council, Buenos 
Aires C1033AAJ, Argentina; cCentro FONDAP de Regulación del Genoma, Facultad de Ciencias, Universidad de 
Chile, Santiago 7800024, Chile; dDepartamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias 
Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1053ABJ, Argentina
ABSTRACT Mammalian insulin-degrading enzyme (IDE) cleaves insulin, among other pep-
tidic substrates, but its function in insulin signaling is elusive. We use the Drosophila system 
to define the function of IDE in the regulation of growth and metabolism. We find that either 
loss or gain of function of Drosophila IDE (dIDE) can restrict growth in a cell-autonomous man-
ner by affecting both cell size and cell number. dIDE can modulate Drosophila insulin-like 
peptide 2 levels, thereby restricting activation of the phosphatidylinositol-3-phosphate ki-
nase pathway and promoting activation of Drosophila forkhead box, subgroup O transcrip-
tion factor. Larvae reared in high sucrose exhibit delayed developmental timing due to insulin 
resistance. We find that dIDE loss of function exacerbates this phenotype and that mutants 
display increased levels of circulating sugar, along with augmented expression of a lipid bio-
synthesis marker. We propose that dIDE is a modulator of insulin signaling and that its loss of 
function favors insulin resistance, a hallmark of diabetes mellitus type II.
INTRODUCTION
In animals, proper balance of energy uptake, storage, and utiliza-
tion relies on coordinated communication between different tissues 
and organs to adjust metabolism according to organism needs. 
This is achieved through paracrine and endocrine signals that act at 
the cellular level to activate signaling pathways that mediate cell 
and organism adaptation. Central among these pathways is the 
phosphatidylinositol-3-phosphate kinase (PI3K) pathway, an evolu-
tionarily conserved signaling cascade that adjusts metabolism 
according to nutrient availability (Britton et al., 2002; Teleman, 
2010). In mammals, glucose levels and metabolism are fine-tuned 
by insulin, which is secreted by pancreatic β-cells and delivered 
through the bloodstream to target tissues. Insulin binds its receptor 
on the plasma membrane of target tissues, activating the PI3K sig-
naling pathway, which increases glucose uptake, storage, and utili-
zation (Leto and Saltiel, 2012).
The insulin signaling pathway is highly conserved between mam-
mals and Drosophila (Bohni et al., 1999; Edgar, 2006). In Drosophila, 
eight insulin-like peptides (dILPs 1–8), homologous to mammalian 
insulin, bind a single receptor, activating the canonical PI3K pathway 
(Brogiolo et al., 2001; Gronke et al., 2010; Colombani et al., 2012; 
Garelli et al., 2012). In the fruit fly the insulin signaling pathway not 
only regulates metabolism through a unique insulin receptor, but 
also controls tissue growth in a similar way as insulin-like growth fac-
tors (IGFs) and IGF receptors do in mammals (Edgar, 2006). For this 
reason, the insulin cascade is known as the insulin/insulin-like signal-
ing (IIS) pathway. dILP and IIS signaling is central for coupling growth 
and developmental programs with the nutritional status of the or-
ganism (Edgar, 2006).
In recent years, significant information has been gained regard-
ing the control of dILP transcription and release (Ikeya et al., 2002; 
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In the present study we use the 
Drosophila system to explore the relation-
ship between dIDE and the IIS pathway. 
Through a genetic approach, we analyze the 
ability of dIDE to regulate Drosophila insu-
lin-like peptide 2 (dILP2) levels and thereby 
modulate metabolism and growth in a nor-
mal or a high-sugar diet. We propose that 
dIDE is a negative regulator of the PI3K 
pathway and that dIDE loss of function con-
tributes to insulin resistance.
RESULTS
dIDE is expressed ubiquitously
To begin investigating the function of dIDE, 
we analyzed the temporal and spatial ex-
pression pattern of its transcript. We ex-
tracted total RNA at different stages of the 
fruit fly life cycle and analyzed dIDE tran-
script levels by real-time PCR. We observed 
that dIDE mRNA levels are maximal in adult 
males, although dIDE expression can be 
detected throughout the life cycle 
(Figure 1A). Next we compared the ex-
pression of the transcript in different larval 
tissues, finding that the highest expression 
occurs in the fat body, with significant ex-
pression in other tissues as well (Figure 1B). 
In publicly available databases on high-
throughput transcriptomic analyses, those 
variations of dIDE expression in the life cy-
cle and between organs have not been ob-
served (Graveley et al., 2011; Marygold 
et al., 2013). To complete the analysis of 
dIDE transcriptional profile, we isolated a 
genomic region encompassing 2.9 kb up-
stream of the dIDE translation initiation site, including the dIDE 
putative promoter, and generated a dide–green fluorescent pro-
tein (GFP) reporter line. As depicted in Figure 1, C–J, the reporter 
was strongly expressed in salivary glands (Figure 1C), fat body 
(Figure 1D), gut (Figure 1, E–G), imaginal disc (Figure 1H), tracheae 
(Figure 1I), and brain (Figure 1J). Taken together, these results sug-
gest that dIDE is expressed in all Drosophila organs and cell types 
throughout the life cycle.
dIDE can modulate dILP levels
Because insulin is the most prominent substrate of mammalian 
IDE, we sought to analyze whether dIDE is capable of cleaving 
dILPs. Available anti-dILP antibodies are not sensitive enough to 
detect endogenous dILPs in Western blots, but one antibody can 
recognize overexpressed levels of this peptide (Figure 2A). We 
therefore performed an experiment in which dIDE and dILP2 were 
coexpressed ubiquitously and analyzed the levels of dILP2. dIDE 
was expressed throughout development in a UAS-dIDE transgenic 
line controlled by an actin-Gal4 driver in combination with the ex-
pression of dILP2 under direct control of a heat shock promoter. 
dILP2 was induced by exposing third-instar larvae to a 15-min heat 
shock, 4 h after which, whole-body homogenates were prepared 
for Western blot analysis. As shown in Figure 2, A and B, dILP2 
levels were significantly reduced in larvae that overexpressed 
dIDE. These results suggest that the metalloprotease dIDE can 
cleave dILP2.
Geminard et al., 2009; Gronke et al., 2010), but little is known 
about how dILP activity is terminated. This is an important aspect 
of IIS pathway regulation since, to attain a correct physiological 
outcome, not only is it important to have tight regulation of the 
initiation of the response, but it is also critical to shut down the 
cascade when it is no longer needed (Duckworth et al., 1998). Evi-
dence for insulin degradation as a plausible mechanism for IIS 
down-regulation emerged with the description of the insulin-de-
grading enzyme (IDE), a zinc metalloprotease with the capacity to 
cleave a wide array of small peptides, with insulin being the sub-
strate with highest affinity (Duckworth et al., 1998). Although the 
structure of human IDE has been resolved and its biochemical 
mechanism of action described in some detail, the physiological 
relevance of its insulin-degrading activity is unclear (Shen et al., 
2006; Im et al., 2007).
The Drosophila melanogaster insulin-degrading enzyme (dIDE) 
displays 44% amino acid identity with human IDE (Shen et al., 2006) 
and is capable of cleaving mammalian insulin in vitro (Garcia et al., 
1988; Duckworth et al., 1989; Kuo et al., 1991). Its overexpression 
provokes phenotypes that are presumably related to insulin defi-
ciency (Tsuda et al., 2010). The variety of genetic tools available in 
the fruit fly, the increasing knowledge on IIS pathway regulation, and 
the occurrence of structural and functional similarities with mamma-
lian systems (Teleman, 2010) provide an opportunity to use this 
model organism to define the involvement of IDE in PI3K signaling 
and associated pathologies.
FIGurE 1: dIDE gene expression pattern. (A) Temporal variation of the expression of dide 
throughout the life cycle, as determined by qRT-PCR. Error bars represent SD (three 
independent experiments). (B) Expression of dide in third-instar larval organs. mRNA levels were 
determined by qRT-PCR. Error bars represent SD (three independent experiments). 
(C–J) Expression of dide in third-instar larval organs, as revealed by expression of a nuclear GFP 
reporter under the control of the dide promoter; representative organs. (C) Salivary glands, 
(D) fat body, (E) anterior gut and proventriculus, (F) midgut, (G) hindgut, (H) wing imaginal disc, 
(I) tracheae, and (J) brain. Bars, 50 μm.
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tion would be systemic rather than cell autonomous. We investi-
gated this issue in wing discs. The adult wing is a bilayer of cells, so 
growth defects in the wing disc dorsal compartment give rise to a 
smaller dorsal wing layer that ultimately generates wings that are 
curved upward (Raisin et al., 2003). This was exactly what we ob-
served after expressing dIDE in this disc territory: the wings were 
curved upward (Figure 3, B and C), indicating that dIDE can restrict 
growth in a cell-autonomous manner. To further analyze and quan-
tify this effect, we expressed dIDE at the wing disc posterior com-
partment by using an engrailed-Gal4 driver (en-Gal4); we observed 
19.1% reduction of region D of the wing at the posterior compart-
ment (Birdsall et al., 2000), suggesting again that the effect of dIDE 
is cell autonomous (Figure 3, D–F). Because insulin signaling is 
known to regulate organ growth by controlling both cell number 
and cell size, we quantified the contribution to growth reduction of 
each of these two parameters. To this end, we determined cell den-
sity at the posterior compartment of the wing by counting the hairs 
in a fixed area. The quantification revealed that IDE overexpression 
increases cell density by 11.2%, and therefore the cells are on aver-
age 11.2% smaller than those of control wings (Figure 3G). Because 
cell size reduction accounts only partially for posterior compartment 
reduction (19.1%), we inferred that the latter originates from a com-
bination of reduced cell size and reduced cell number. These con-
clusions were further confirmed by counting directly the cells after 
overexpression of dIDE under control of a patched-Gal4 driver in 
region C of the wing (Figure 3D). Also in this case, reduction of the 
area occurred specifically in the wing territory that overexpressed 
the enzyme, and this reduction resulted 
from a combination of decreased cell size 
and decreased cell number (Supplemental 
Figure S1).
dIDE-dependent growth reduction 
is mediated by the PI3K pathway 
in a cell-autonomous manner
Given that dILPs activate the PI3K path-
way upon binding the insulin receptor 
(InR), we sought to investigate whether 
regulation of this pathway mediates the 
effect of dIDE. Drosophila phosphatase 
and tensin homologue on chromosome 
10 (PTEN) is a phosphatidylinositol 
(3,4,5)-triphosphate phosphatase that 
negatively regulates PI3K signaling down-
stream of the InR (Goberdhan et al., 1999; 
Huang et al., 1999), so it is expected that 
PTEN reduction of function will antago-
nize the effect of dIDE. Indeed, as de-
picted in Figure 4, A–C and E, loss of one 
dose of PTEN largely suppresses dIDE-
dependent growth impairment, support-
ing the notion that dIDEs exerts its effect 
by modulating PI3K pathway activation.
The PI3K pathway signals in part through 
Drosophila forkhead box, subgroup O tran-
scription factor (FOXO). Activation of the 
cascade leads to phosphorylation and nu-
clear exclusion of FOXO, resulting in re-
duced FOXO-dependent transcription 
(Junger et al., 2003; Puig et al., 2003). To 
investigate whether dILP-dependent reduc-
tion of growth is mediated in part by FOXO, 
dIDE provokes growth reduction in a cell-autonomous 
manner
Given that dIDE is capable of reducing dILP2 levels, we sought to 
determine whether expression of this metalloprotease affects 
growth. Initially, we expressed dIDE ubiquitously through an actin-
Gal4 driver and observed 12.3% reduction of pupal volume in com-
parison to control individuals (Figure 3A). One possibility is that 
dIDE cleaves dILPs in the hemolymph, thereby limiting their access 
to target tissues. If this were the case, the effect of dIDE manipula-
FIGurE 2: dIDE expression reduces dILP2 levels. (A) Anti-dILP2 
Western blot of whole third- instar larval extracts prepared from 
individuals overexpressing dILP2 and coexpressing or not dIDE. 
Expression of dIDE provokes reduction of dILP2 levels. 
(B) Quantification of the Western blot. Error bars represent SEM 
(*p < 0.05; Student’s t test, n = 5).
FIGurE 3: dIDE provokes growth reduction in a cell-autonomous manner. (A) Pupae from 
individuals that express transgenic dIDE ubiquitously are significantly smaller than those of control 
siblings, as determined by their pupal volume (see Materials and Methods). Error bars represent 
SEM (**p < 0.001; Student’s t test; n ≥ 30 in three independent experiments). (B, C) Expression of 
dIDE in the dorsal compartment of the wing imaginal disc generates upwardly curved wings, 
indicating reduction of growth of this compartment. (D, E) Expression of dIDE at the posterior 
compartment of the disc provokes a reduction of the posterior half of the wing; this was 
estimated by measuring the area of the wing region D (indicated by the broken line in D, E). 
(F) Quantification of wing areas marked in D and E. Error bars represent SEM (**p < 0.001; 
Student’s t test; n ≥ 20 in three independent experiments). (G) Wing hair density at the posterior 
compartment of the wing. Following expression of dIDE, hair density increased, indicating that 
cell size was reduced. Cell size reduction accounts only partially for reduction of the area of the 
wing posterior compartment; compare delta values in F (19.1%) and G (11.2%). The remaining 
reduction of the area is due to decreased number of cells in the compartment. Error bars 
represent SEM (**p < 0.001; Student’s t test; n ≥ 20 in three independent experiments).
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(Figure 4F). To confirm that dIDE can in-
crease FOXO-dependent transcription, we 
examined the induction of the FOXO target 
gene thor (Teleman et al., 2005) by using a 
thor-LacZ enhancer trap. As depicted in 
Figure 4, G and H, β-galactosidase expres-
sion was detected only at the posterior wing 
disc compartment of en-Gal4/UAS-dIDE in-
dividuals, confirming that dIDE indeed in-
duces FOXO-dependent transcription and 
that the effect of dIDE is cell autonomous. 
Consistent with the experiments described 
earlier, expression of thor-LacZ was largely 
suppressed in larvae that were heterozygous 
for FOXO (Figure 4, I and J). Taken together, 
these results suggest that dIDE-dependent 
growth reduction is mediated by a cell-au-
tonomous mechanism that involves the 
negative regulation of the PI3K pathway 
and consequent activation of the transcrip-
tion factor FOXO.
dIDE accumulates in the cytoplasm and 
plasma membrane of the cells in which 
it is expressed
The cell-autonomous effect of dIDE sug-
gested that the enzyme is not secreted 
freely to the hemolymph but instead exerts 
its effect locally in the cell in which it is ex-
pressed. To analyze this, we generated a 
transgenic line expressing a dIDE:GFP fu-
sion protein, which was initially induced at 
the wing imaginal disc under control of a 
ptc-Gal4 driver. dIDE:GFP did not diffuse 
away from the row of ptc-positive cells 
(Figure 5A). Instead, part of the fusion pro-
tein accumulated at the plasma membrane, 
and no protein could be detected at the lu-
men of the imaginal disc between the co-
lumnar epithelium and the peripodial mem-
brane (Figure 5, B and C). The expression of 
dIDE:GFP in the patched expression pattern 
provokes reduction of the distance between 
veins III and IV, which is even more pro-
nounced than the reduction elicited by the 
expression of the untagged dIDE (Figure 5, 
D–G). This indicates that dIDE:GFP is bio-
logically active, suggesting that subcellular 
localization of the GFP fusion protein reca-
pitulates the localization of endogenous 
dIDE. ptc-Gal4 drives transgene expression 
also in the salivary gland, so we studied sub-
cellular localization of dIDE:GFP in this or-
gan. In this case too, the fusion protein ap-
peared to be retained in the cytosol and 
accumulated in the plasma membrane, whereas no protein ap-
peared to be secreted to the extracellular milieu (Supplemental 
Figure S2, A–F). Remarkably, the size of the salivary gland express-
ing dIDE:GFP was autonomously reduced (Supplemental Figure S2, 
G and H), confirming again that the effect of dIDE is cell autono-
mous. Taken together, the foregoing experiments suggest that dIDE 
is retained in the cytoplasm and plasma membrane of the cell in 
we took a genetic approach similar to that described for PTEN. We 
observed that FOXO reduction of function antagonized the effect of 
dIDE, as the wing curvature observed upon expression of dIDE in 
the dorsal compartment was partially suppressed in FOXO-heterozy-
gous individuals (Figure 4, A, B, and D), and similarly, the reduction 
of the wing posterior compartment observed upon en-Gal4 driven 
expression of dIDE was also suppressed in FOXO heterozygotes 
FIGurE 4: Reduction of growth upon dIDE expression is mediated by the PI3K pathway. 
(A–D) The wing curvature provoked by the expression dIDE at the dorsal compartment of the 
imaginal disc (A, B) is partially suppressed in flies lacking one dose of PTEN (C) or FOXO (D). 
(E, F) Reduction of the area of the posterior compartment provoked by the expression of dIDE 
under control of an en-Gal4 driver (assessed by determination of the wing region D) is partially 
reverted in individuals lacking one dose of PTEN (E) or FOXO (F). These results (A–F) indicate 
that the PI3K pathway mediates dIDE-dependent growth reduction through the regulation of 
FOXO. Error bars represent SEM (p < 0.05; one-way analysis of variance (ANOVA) with Tukey 
post hoc test; means with a letter in common are not significantly different; n ≥ 20 in three 
independent experiments). (G, H) The FOXO target gene thor is induced at the posterior 
compartment of the wing imaginal disc upon expression of dIDE in the same compartment, 
suggesting that dIDE-dependent inactivation of the PI3K pathway and activation of FOXO is cell 
autonomous. In foxo25 (I) or foxo21 (J) heterozygous mutant larvae, dIDE-dependent thor 
transcription is reduced, confirming that FOXO mediates thor-LacZ induction in this setting. 
Bar, 100 μm.
920 | D. Galagovsky et al. Molecular Biology of the Cell
the area of the posterior compartment of 
the wing in comparison to control flies 
(Figure 6F). Taken together, the results in-
dicate that dIDE loss of function provokes 
growth reduction in a cell-autonomous 
manner. As a next step, we investigated 
whether reduced activation of the PI3K 
pathway accounts for growth reduction 
also in this setting. Following an approach 
similar to the one utilized earlier, we ex-
pressed dIDE RNAi in the wing disc poste-
rior compartment of larvae that were 
heterozygous for PTEN or FOXO mutant 
alleles. Area reduction of the posterior 
wing compartment was strongly sup-
pressed in both PTEN (3.2%) and FOXO 
(3.9%) heterozygotes (Figure 6, F and G), 
suggesting that reduction of PI3K signal-
ing accounts for growth impairment upon 
dIDE silencing. To get further evidence 
that FOXO mediates this growth reduc-
tion, we examined whether transcript lev-
els of the FOXO target gene thor increase 
upon expression of dIDE RNAi. Silencing 
of dIDE in the fat body provoked strong 
up-regulation of thor transcription, and 
this up-regulation was completely sup-
pressed in PTEN-heterozygous larvae 
(Supplemental Figure S5). Taken together, 
these results indicate that dIDE silencing 
provokes activation of the transcription 
factor FOXO through the inhibition of the 
PI3K pathway.
Given that dIDE can negatively regulate 
dILP availability and growth (Figure 2) and 
that this effect is mediated by the PI3K path-
way (Figure 4), the reduction of growth ob-
served upon dIDE knockdown seems para-
doxical at first glance. However, it was 
recently shown that Drosophila larvae reared 
in a high-sucrose diet, albeit displaying aug-
mented levels of circulating dILPs, exhibit 
reduced growth and delayed developmental timing (Musselman 
et al., 2011; Pasco and Leopold, 2012). Physiological characteriza-
tion of these larvae revealed that growth impairment was due to a 
phenomenon known as insulin resistance (Musselman et al., 2011; 
Pasco and Leopold, 2012). We therefore investigated whether dIDE 
loss of function enhances insulin resistance in Drosophila larvae ex-
posed to a high-sucrose diet.
We raised wild-type individuals and larvae homozygous for the 
dIDEKO null allele either in regular food (0.2 M sucrose) or in a high-
sucrose culture medium (1 M sucrose). As depicted in Figure 6H, 
under regular feeding conditions, wild-type and IDEKO larvae devel-
oped almost at the same rate. As previously reported (Musselman 
et al., 2011; Pasco and Leopold, 2012), in high-sucrose medium 
wild-type larvae exhibited a conspicuous developmental delay, pu-
pariating 3 d later than in normal culture medium. Of interest, the 
delay provoked by the high-sugar diet was enhanced in dIDEKO lar-
vae, which pupariated >1 d later than wild-type individuals 
(Figure 6H). Similar results were obtained when reduction of dIDE 
levels were attained by ubiquitous expression of dIDE RNAi 
(Supplemental Figure S6).
which it is expressed, explaining its cell-autonomous effect on 
growth regulation and modulation of the PI3K pathway.
Down-regulation of dIDE provokes reduction of tissue 
growth and sensitizes developmental timing and 
metabolism to high-sucrose diets
Next we sought to study the effect of dIDE loss of function on 
growth and metabolism. We analyzed in detail a dIDE-null mutant 
line generated by gene targeting (Tsuda et al., 2010) and found 
that pupal volume of these mutants is significantly reduced in 
comparison to wild-type siblings (Figure 6A). dIDE RNA interfer-
ence (RNAi) is efficient in mediating reduction of dIDE transcript 
levels (Supplemental Figure S3), so it was used to analyze whether 
the growth reduction observed in the dIDE mutants is cell autono-
mous. Indeed, this was the case, as expression of the RNAi in the 
wing disc dorsal compartment provoked a clear reduction of com-
partment size (Figure 6, B and C, and Supplemental Figure S4), 
which resulted in adult wings that were curved upward (Figure 6D 
and E). Similarly, expression of dIDE RNAi at the posterior com-
partment of the wing disc provoked a clear (13.9%) reduction of 
FIGurE 5: dIDE localizes in the cytoplasm and plasma membrane of wing imaginal disc cells. 
Expression of a dIDE:GFP fusion protein was induced in the wing imaginal disc through a 
ptc-Gal4 driver. (A) The fusion protein can be detected only in the narrow stripe of cells (two to 
four cells) that expresses patched, without any indication that the protein can move away into 
neighboring cells. (B) Longitudinal and (C) transverse z-sections of the wing disc showing that 
the fusion protein accumulates in the cytoplasm and plasma membrane (arrowheads) of 
ptc-expressing cells; scale bar, 50 μm. (D–F) The expression of dIDE (E) or dIDE:GFP (F) under 
control of the ptc-Gal4 driver reduces the distance between veins III and IV (shown in D) as 
compared with control wings expressing GFP alone (D). (G) Quantification of the effect of dIDE 
or dIDE:GFP expression on the reduction of the distance between veins III and IV. The effect of 
dIDE:GFP (30% reduction) is stronger than that of dIDE alone (12.6% reduction). The distance 
between veins III and IV is indicated as a (green line) in D. The distance a was normalized to the 
length of vein III, indicated as b (red line; **p < 0.001; one-way ANOVA with Tukey post hoc 
test; n ≥ 20 in three independent experiments).
Volume 25 March 15, 2014 Cell-autonomous effect of dIDE | 921 
ACC in dIDEKO and wild-type larvae reared in either regular medium 
or a high-sugar diet. We found that ACC transcription was strongly 
upregulated in IDEKO flies in both regular and high-sugar food 
(Figure 6J), suggesting that dIDE knockdown affects lipid metabo-
lism. Taken together, the foregoing results suggest that dIDE loss of 
function favors the manifestation of several phenotypes that are re-
lated to insulin resistance.
DISCUSSION
In this work we showed that dIDE has the capacity to modulate 
dILP2 levels, regulate the PI3K pathway, and affect growth. The 
growth phenotypes observed upon dIDE manipulation depend at 
least in part on the transcription factor FOXO, one of the main effec-
tors of the PI3K pathway. Because dIDE-null mutants are homozy-
gous viable to adulthood, dIDE is probably not a core regulator of 
the PI3K pathway but instead a modulator of this cascade that con-
tributes to fine-tuning fly growth and metabolism. We showed that 
both dIDE gain and loss of function bring about diminished growth, 
results that, at first glance, seem paradoxical. Nevertheless, dimin-
ished signaling in conditions of increased insulin has been reported 
In mammals, insulin resistance provokes hyperglycemia in fasting 
conditions, derived in part from reduced capacity of the tissues to 
incorporate glucose, resulting in higher-than-normal circulating 
sugar levels. To test whether dIDEKO individuals display this meta-
bolic phenotype, we subjected wild-type and dIDEKO adult flies to 
24-h starvation, after which we measured circulating levels of the 
disaccharide trehalose, the main circulating sugar in insects. As de-
picted in Figure 6I, in wild-type flies trehalose levels dropped sharply 
after 24-h starvation, whereas in dIDEKO flies, trehalose levels re-
mained close to those observed before starvation. These results 
suggest that dIDE is necessary for adjusting the levels of circulating 
sugar levels in response to variations of the feeding conditions.
Obesity is another feature associated with insulin resistance, 
which originates at least in part from higher-than-normal levels of 
circulating triacylglycerol (TAG) and increased lipid storage. TAG 
levels are known to be regulated the PI3K pathway in Drosophila (Xu 
et al., 2012). It was reported that increased lipid levels correlate with 
augmented expression of the acetyl CoA carboxylase (ACC) gene 
transcript (Pasco and Leopold, 2012), the enzyme that catalyses the 
first step in fatty acid biosynthesis. We analyzed transcription of 
FIGurE 6: dIDE loss of function provokes reduction of growth and sensitization to a high-sugar diet. (A) dIDEKO pupae 
are significantly smaller than those of control (WT) siblings, as assessed by calculating their pupal volume (see Materials 
and Methods). Error bars represent SEM (**p < 0.001; Student’s t test; n ≥ 30 in three independent experiments). 
(B, C) The dorsal compartment of the wing imaginal disc is autonomously reduced upon dIDE RNAi expression. Disc 
compartments can be visualized by the expression of Wingless (Wg, green); d, disc dorsal compartment; v, disc ventral 
compartment. Bar, 100 μm. (D, E) dIDERNAi-dependent autonomous growth reduction of the dorsal compartment 
resulted in wings curved upward. (F, G) dIDERNAi expression at the posterior compartment of the wing disc provoked 
autonomous reduction of this compartment, as assessed by determination of the area of region D. Expression of RNAi 
in PTEN (F) or FOXO (G) heterozygous mutants caused strong suppression of growth impairment. Error bars represent 
SEM (p < 0.05; one way ANOVA with Tukey post hoc test; means with a letter in common are not significantly different; 
n ≥ 20 in three independent experiments). (H) dIDEKO and control larvae pupariate almost at the same time in standard 
culture medium. In a high-sugar culture medium, significant delay of pupariation of wild-type individuals occurred; this 
delay was increased in dIDEKO larvae. Error bars represent SD (**p < 0.001; two-way ANOVA with Duncan post hoc test; 
n = 60 in six independent experiments). (I) In WT adult flies, trehalose levels in hemolymph dropped significantly after 
24-h starvation; in dIDEKO individuals subjected to starvation, trehalose levels remained similar to those of well-fed 
animals. Error bars represent SEM (ns, non significant; *p < 0.05; two-way ANOVA with Tukey post hoc test; n = 5). 
(J) dIDEKO flies display augmented levels of the acetyl CoA carboxylase (ACC) transcript, used as an indicator of TAG 
metabolism. In high-sugar medium, ACC expression increased significantly in wild-type larvae, but ACC transcript levels 
in dIDEKO individuals were even higher. Error bars represent SEM (**p < 0.001; two-way ANOVA with Tukey post hoc 
test; n = 3).
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precise subcellular location of dIDE and particularly the functional 
relevance of its possible role in early endosomes.
MATERIALS AND METHODS
Fly stocks
For the generation of UAS-dIDE lines we amplified the dide open 
reading frame by PCR from the EST RE17458 (DGRC). For genera-
tion of the dide nGFP expression reporter we cloned a 2-kb fragment 
upstream of the translation initiation site with the primers 5′-GGGG-
TACCCCTTGGGTTTTATAAGCGTGCCAATCG-3′ and 5′-GAAGAT-
CTTCAATACATGGCAATCGGTTCCAC-3′, which include sites for 
KpnI and BglII, in a pStinger (Barolo et al., 2000) nGFP vector. For the 
UAS-dIDE:GFP transgenic line we cloned the dIDE gene by remov-
ing the stop codon by PCR using the primers 5′-GACGAATTCATG-
TATCTTACGTGCAGAAAATCG-3′ and 5′-CGGGGTACCGTAAGCT-
TGCTGCGTGCTCCCTTCG-3′ (including sites for EcoRI and KpnI 
restriction enzymes, respectively) into a pEGFP-N1 plasmid and then 
subcloned the fusion protein construct into a pUAST-attB plasmid 
(Bischof et al., 2007). Transgenic lines were generated by embryo 
germline transformation (Spradling and Rubin, 1982).
We used the following stocks from the Bloomington Drosophila 
Stock Center (Indiana University, Bloomington, IN): En-Gal4 (#6356), 
MS1096 (#8696), Ap-Gal4 (#3041), Act-Gal4 (#3954, #4414), ptc-
Gal4 (#2017), and thor1 (#9558). The following stocks were from the 
Vienna Drosophila RNAi Center: UAS-dIDERNAi (#15957 and #15958) 
and UAS-Dcr2 (#60009). The following stocks were obtained from 
different colleagues: PTEN2L117 (Oldham et al., 2000), FOXO21 and 
FOXO25 (Junger et al., 2003), hs-dilp2 (Rulifson et al., 2002), and 
IDEKO (Tsuda et al., 2010). Controls for the experiments with IDEKO 
mutants were performed in the y,w background line.
Anti-dILP2 Western blots
First-instar larvae overexpressing or not dIDE were sorted and placed 
in groups of 60 individuals/vial. First, larvae were exposed to a 
15-min heat shock at 37°C and then placed at 25°C for 4 h. Larvae 
were then recovered, rinsed in phosphate-buffered saline (PBS), and 
homogenized in lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1 mM 
ethylene glycol tetraacetic acid, 1% NP-40, Sigma Protease Inhibitor 
Cocktail). After centrifugation, samples were loaded in 10% 
SDS–PAGE gels, run, and transferred to an Immobilon-PSQ mem-
brane (Millipore, Billerica, MA). Membranes were incubated with 
1:1000 anti-dilp2 antibody (gift from Hugo Stocker, ETHZ, Zürich, 
Switzerland), revealed with Amersham ECL Prime (GE Healthcare, 
Pittsburgh, PA), and scanned. Bands were quantified using ImageJ 
software (National Institutes of Health, Bethesda, MD).
Immunostaining and X-Gal staining
For immunostaining, larvae were dissected in PBS and fixed in PBS/
Triton 0.1% (PBST) and formaldehyde 4% for 20 min at room tem-
perature. Samples were washed with PBST and blocked with PBST 
bovine serum albumin 5%, followed by incubation with a primary 
antibody overnight at 4°C, washed, and incubated 4 h at room tem-
perature with secondary antibodies conjugated to fluorophores. 
Phalloidin (1:200; Sigma, St. Louis, MO) was added during the last 
30 min of secondary antibody incubation. Samples were then washed 
and mounted in PBST glycerol 80%. Antibodies used in this study 
were anti-GFP (1:1000, A-11122; Invitrogen, Carlsbad, CA) and anti-
Wingless (1:1000, 4D4; Developmental Studies Hybridoma Bank, 
Iowa City, IA). Images were captured in a Carl Zeiss LSM510 Meta 
Confocal Microscope.
For X-Gal staining, larvae were dissected in PBS and fixed 10 min 
in a 16.67 mM KH2PO4/K2HPO4 (pH 6.8), 75 mM KCl, 25 mM NaCl, 
and is known as insulin resistance, a hallmark of human diabetes 
mellitus type II (DMII; Zimmet et al., 2001). In a DMII Drosophila 
model, larvae fed with a high-sugar diet display higher-than-normal 
levels of circulating dILP2, along with reduced PI3K signaling in tar-
get tissues (Musselman et al., 2011; Pasco and Leopold, 2012).
The mechanisms of the genesis and progression of DMII are un-
clear. Although obesity, high-sugar diets, and fat-rich diets are well-
established predisposition factors for the disease (Zimmet et al., 
2001; Venables and Jeukendrup, 2009), genetic risk factors have 
also been proposed (Stumvoll et al., 2008; Ridderstrale and Groop, 
2009). It is noteworthy that association between IDE loss-of-function 
and DMII has been reported, as human populations with mutations 
in the IDE locus display increased incidence of this disease 
(Karamohamed et al., 2003; Rudovich et al., 2009). In keeping with 
this observation, the GK rat, an animal model that recapitulates 
most of the features of human DMII (Goto et al., 1976), was found to 
carry loss-of-function mutations in the IDE locus (Fakhrai-Rad et al., 
2000; Farris et al., 2004). Experimental evidence for a role of IDE in 
the etiology of DMII came shortly afterward with the generation of 
IDE-knockout mice, which display hyperinsulinemia and glucose in-
tolerance (Farris et al., 2003; Abdul-Hay et al., 2011). Even though 
the mechanisms linking IDE to the genesis of DMII are elusive, a 
simple explanation would be that reduced degradation of insulin 
leads to increased insulinemia, which in turn provokes reduced insu-
lin sensitivity due to increased receptor internalization. In this 
simplistic model, IDE is predicted to operate in the bloodstream, 
mediating insulin clearance from circulation. If this model is correct, 
IDE should be secreted from the cell and mediate insulin degrada-
tion extracellularly (i.e., in the bloodstream), behaving in a nonauto-
nomous manner.
Although several studies revealed that IDE can be secreted to 
the extracellular milieu (Goldfine et al., 1984; Seta and Roth, 1997; 
Vekrellis et al., 2000; Bulloj et al., 2010), other works reported the 
occurrence of the enzyme at other locations, such as the plasma 
membrane, endosomes, peroxisomes, mitochondria, and cytosol 
(Hamel et al., 1991; Authier et al., 1994; Morita et al., 2000; Leissring 
et al., 2004). In rat liver parenchymal cells the early endosome is a 
major site of degradation of insulin, although IDE was found to be 
cytosolic and thus is apparently not involved in endosomal degrada-
tion in this tissue (Pease et al., 1985; Backer et al., 1990; Doherty 
et al., 1990; Authier et al., 1994).
In the present study, we found that IDE is in part associated with 
the plasma membrane, without any evidence of its being secreted. 
We provided clear evidence that its effect on growth regulation is 
cell autonomous, and so it is its capacity to modulate activation of 
the PI3K pathway. Thus, based on our genetic evidence, an attractive 
possibility is that dIDE is associated to plasma membrane domains 
that are in close proximity to insulin receptors, and so after binding 
of the ligand, dIDE is endocyted together with the receptor–ligand 
complex. Once in early endosomes, dIDE cleaves the ligand, con-
tributing to recycling the receptor to the plasma membrane.
Of interest, it was suggested for other receptor tyrosine kinases 
that cleavage of the ligand at the early endosome is important for 
recycling the receptor to the plasma membrane (Sorkin and Von 
Zastrow, 2002). So, if Drosophila IDE does indeed exert its function 
at early endosomes, knockdown of dIDE is expected to cause re-
duction of dILP proteolysis in this compartment, leading to impair-
ment of recycling of insulin receptors to the membrane, ultimately 
provoking insulin resistance. In this scenario, overexpression of dIDE 
may increase dILP proteolysis at the plasma membrane before 
ligand binding to the receptor, thereby reducing PI3K signaling. 
Detailed biochemical and cellular studies are required to define the 
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3.33 mM MgCl2, 5% glutaraldehyde buffer at room temperature. 
Samples were then washed with PBST and incubated overnight with 
the staining solution (5 μM K4Fe(CN)6, 5 μM K3Fe(CN)6, 0.2%X-Gal) 
at room temperature. Samples were then washed and mounted for 
observation and photographed using an Olympus BX60 microscope 
equipped with an Olympus DP71 digital camera.
Quantitative real-time PCr
The following primers were used for quantitative real-time PCR (qRT-
PCR): for dIDE, 5′-CAACGCCGCCACCTATCC-3′ and 5′-AGAGTT-
TACCGCATTGATTTCCC-3′; for dILP2, 5′-ATCCCGTGATTCCACA-
CAAG-3′ and 5’-GCGGTTCCGATATCGAGTTA-3′; for ACC, 5′-GCT-
TGCGTGATCCCTCGTT-3′ and 5′-GATATGGGTATGCGACCAGA-
GAT-3′; and for Rpl29 to normalize the quantifications. qRT-PCR was 
performed using a Mx3005P QPCR System (Stratagene, La Jolla, 
CA).
Wing measurements
First-instar larvae of the different genotypes were sorted and placed 
in groups of 60 individuals/vial and allowed to develop to adult-
hood. The 2- to 4-d-old adults were collected and conserved in 70% 
ethanol until analysis. The right wings of female individuals were 
removed and mounted in a lactic acid:ethanol (1:1) mixture. Photo-
graphs of the wings were taken with an Olympus MVX10 stereomi-
croscope with an Olympus DP71 digital camera. Quantification of 
the areas was performed with ImageJ.
Developmental timing and pupal size
First-instar larvae of the different genotypes were sorted against 
fluorescent balancer chromosomes and placed in groups of 60 indi-
viduals/vial and raised at 25°C. Developmental timing was assessed 
by counting the pupae in each vial every day at noon. Results were 
plotted, and curves were approximated to a Gompetz model using 
Infostat Statistical Software (Universidad Nacional de Córdoba, Cór-
doba, Argentina). The α, β, and γ parameters were calculated, and 
the time of 50% pupariation was determined for each repeat.
For determining pupal size, pupae were photographed at 10× 
magnification under an Olympus MVX10 stereomicroscope with an 
Olympus DP71 camera and measured using ImageJ. Pupal volume 
was estimated by adjusting it to the volume of a pill with hemi-
spheric ends (V = πD2(3L − D)/12, where D is the width and L is the 
length of the pupa). Standard and high-sugar culture media were 
prepared as previously described (Pasco and Leopold, 2012).
Trehalose determinations
The 2- to 4-d-old adults of each genotype were placed in vials in 
groups of 25 and maintained for 24 h in standard feeding condi-
tions, after which they were transferred for fasting to 3.5-cm-diame-
ter Petri dishes lined with a piece of Whatman No. 1 paper wet in 
PBS. Hemolymph was extracted from groups of 14 females by punc-
turing the thorax with a 0.15-gauge entomological needle and 
placed on a makeshift cage on the top of a 1.5-ml Eppendorf tube 
with a 22-nm nylon mesh. The tubes were centrifuged at 2600 × g 
for 5 min at 4°C. Hemolymph was diluted 1:20 in water and heated 
to 95°C for 5 min. Two microliters of sample were mixed with Fisher 
Hexokinase Reagent (Fisher Scientific, Pittsburgh, PA), and, after 
15-min reaction, absorbance at 340 nm was recorded using a Nano-
drop 1000 apparatus (Thermo Scientific, Wilmington, DE).
Statistical analysis
Infostat Statistical Software and Excel (Microsoft, New York, NY) 
were used for statistical analysis where appropriate.
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